8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published advice accepting three new medicines for use in lung cancer and Hodgkin lymphoma.

Osimertinib (Tagrisso) was accepted for use in patients who have had surgery for non-small cell lung cancer.

Read SMC press release